STOCK TITAN

[Form 4] Assurant, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Jay Rosenblum, EVP and CLO of Assurant, Inc. (AIZ), reported a sale of 3,900 shares of Assurant common stock on 08/12/2025 at a weighted average price of $208.5273. The filing notes the shares were sold in multiple transactions at prices ranging from $208.1150 to $208.8050, and that the reporting person will provide details on the number of shares sold at each price if requested. Following the reported sale, Rosenblum’s beneficial ownership of Assurant common stock is 7,875 shares, which the filing states includes restricted stock units. The Form 4 discloses only non-derivative activity; no options, puts, calls, or other derivative transactions are reported in this filing.

Jay Rosenblum, vicepresidente esecutivo e responsabile legale (CLO) di Assurant, Inc. (AIZ), ha comunicato la vendita di 3,900 azioni ordinarie di Assurant in data 08/12/2025 a un prezzo medio ponderato di $208.5273. La segnalazione indica che le azioni sono state vendute in più transazioni a prezzi compresi tra $208.1150 e $208.8050, e che la persona che ha effettuato la segnalazione fornirà i dettagli sul numero di azioni vendute a ciascun prezzo su richiesta. Dopo la vendita segnalata, la partecipazione beneficiaria di Rosenblum in azioni ordinarie di Assurant è di 7,875 azioni, che il documento dichiara include unità azionarie vincolate. Il Modulo 4 dichiara esclusivamente attività non derivative; non sono segnalate opzioni, put, call o altre operazioni su derivati in questa comunicazione.

Jay Rosenblum, vicepresidente ejecutivo y director jurídico (CLO) de Assurant, Inc. (AIZ), comunicó la venta de 3,900 acciones ordinarias de Assurant el 08/12/2025 a un precio medio ponderado de $208.5273. El informe señala que las acciones se vendieron en varias transacciones a precios entre $208.1150 y $208.8050, y que la persona que informa facilitará los detalles sobre el número de acciones vendidas a cada precio si se lo solicitan. Tras la venta comunicada, la participación beneficiaria de Rosenblum en acciones ordinarias de Assurant es de 7,875 acciones, que el informe indica incluye unidades restringidas de acciones. El Formulario 4 revela únicamente actividad no derivada; no se informan opciones, puts, calls ni otras operaciones con derivados en este documento.

Jay Rosenblum은(는) Assurant, Inc. (AIZ)의 수석부사장 겸 최고법률책임자(CLO)로서 08/12/2025에 Assurant 보통주 3,900주를 가중평균 가격 $208.5273에 매도했다고 보고했습니다. 신고서에는 해당 주식이 $208.1150에서 $208.8050 사이의 가격으로 여러 거래에서 매도되었으며, 신고인은 요청 시 각 가격대별 매도 주식 수에 대한 세부 정보를 제공하겠다고 기재되어 있습니다. 보고된 매도 후 Rosenblum의 Assurant 보통주에 대한 실소유(beneficial ownership)는 7,875주이며, 신고서에는 이 수치가 제한부여주식단위(RSU)를 포함한다고 명시되어 있습니다. 이 Form 4는 비파생거래(비-파생상품)만을 공개하며, 이 제출서에는 옵션, 풋, 콜 또는 기타 파생상품 거래가 보고되어 있지 않습니다.

Jay Rosenblum, vice-président exécutif et directeur juridique (CLO) d'Assurant, Inc. (AIZ), a déclaré la vente de 3,900 actions ordinaires d'Assurant le 08/12/2025 à un prix moyen pondéré de $208.5273. Le dépôt indique que les actions ont été vendues lors de plusieurs transactions à des prix allant de $208.1150 à $208.8050, et que la personne ayant effectué la déclaration fournira, sur demande, des détails sur le nombre d'actions vendues à chaque prix. Après la vente déclarée, la participation bénéficiaire de Rosenblum dans les actions ordinaires d'Assurant s'élève à 7,875 actions, que le dépôt précise comprend des unités d'actions restreintes. Le formulaire 4 divulgue uniquement des opérations non dérivées ; aucune option, put, call ou autre opération sur dérivés n'est signalée dans ce document.

Jay Rosenblum, Executive Vice President und Chief Legal Officer (CLO) von Assurant, Inc. (AIZ), meldete am 08/12/2025 den Verkauf von 3,900 Stammaktien von Assurant zu einem gewichteten Durchschnittspreis von $208.5273. Die Meldung führt aus, dass die Aktien in mehreren Transaktionen zu Preisen zwischen $208.1150 und $208.8050 verkauft wurden und dass die meldepflichtige Person auf Anfrage Angaben zur Anzahl der zu jedem Preis verkauften Aktien machen wird. Nach dem gemeldeten Verkauf beträgt Rosenblums wirtschaftliches Eigentum an Assurant-Stammaktien 7,875 Aktien, wobei die Meldung angibt, dass dies eingeschränkte Aktieneinheiten (Restricted Stock Units, RSU) beinhaltet. Das Formular 4 offenbart nur nicht-derivative Transaktionen; Optionen, Puts, Calls oder andere Derivatgeschäfte sind in dieser Meldung nicht angegeben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: An executive sale of 3,900 shares was disclosed; ownership after the sale is 7,875 shares including RSUs, with sale prices described.

The Form 4 shows a clear, documented change in beneficial ownership by an executive officer. The filing provides a weighted average sale price of $208.5273 and discloses the price range for multiple transactions, which supports transparency and compliance with Section 16 reporting requirements. The disclosure that remaining holdings include restricted stock units clarifies the composition of retained equity. There are no derivative transactions reported, which simplifies the ownership picture.

TL;DR: Reported sale is a routine insider disposition with specified price range and residual holdings that include RSUs; impact appears neutral.

The filing documents a sale of 3,900 shares at a weighted average of $208.5273, with sales executed across a range of $208.1150 to $208.8050. The reporter retains 7,875 shares post-transaction, including restricted stock units. From a market-impact perspective, the Form 4 provides the necessary details for investors to track insider liquidity and remaining insider alignment via RSUs, but it does not indicate any associated derivative activity or changes to compensation structure within this filing.

Jay Rosenblum, vicepresidente esecutivo e responsabile legale (CLO) di Assurant, Inc. (AIZ), ha comunicato la vendita di 3,900 azioni ordinarie di Assurant in data 08/12/2025 a un prezzo medio ponderato di $208.5273. La segnalazione indica che le azioni sono state vendute in più transazioni a prezzi compresi tra $208.1150 e $208.8050, e che la persona che ha effettuato la segnalazione fornirà i dettagli sul numero di azioni vendute a ciascun prezzo su richiesta. Dopo la vendita segnalata, la partecipazione beneficiaria di Rosenblum in azioni ordinarie di Assurant è di 7,875 azioni, che il documento dichiara include unità azionarie vincolate. Il Modulo 4 dichiara esclusivamente attività non derivative; non sono segnalate opzioni, put, call o altre operazioni su derivati in questa comunicazione.

Jay Rosenblum, vicepresidente ejecutivo y director jurídico (CLO) de Assurant, Inc. (AIZ), comunicó la venta de 3,900 acciones ordinarias de Assurant el 08/12/2025 a un precio medio ponderado de $208.5273. El informe señala que las acciones se vendieron en varias transacciones a precios entre $208.1150 y $208.8050, y que la persona que informa facilitará los detalles sobre el número de acciones vendidas a cada precio si se lo solicitan. Tras la venta comunicada, la participación beneficiaria de Rosenblum en acciones ordinarias de Assurant es de 7,875 acciones, que el informe indica incluye unidades restringidas de acciones. El Formulario 4 revela únicamente actividad no derivada; no se informan opciones, puts, calls ni otras operaciones con derivados en este documento.

Jay Rosenblum은(는) Assurant, Inc. (AIZ)의 수석부사장 겸 최고법률책임자(CLO)로서 08/12/2025에 Assurant 보통주 3,900주를 가중평균 가격 $208.5273에 매도했다고 보고했습니다. 신고서에는 해당 주식이 $208.1150에서 $208.8050 사이의 가격으로 여러 거래에서 매도되었으며, 신고인은 요청 시 각 가격대별 매도 주식 수에 대한 세부 정보를 제공하겠다고 기재되어 있습니다. 보고된 매도 후 Rosenblum의 Assurant 보통주에 대한 실소유(beneficial ownership)는 7,875주이며, 신고서에는 이 수치가 제한부여주식단위(RSU)를 포함한다고 명시되어 있습니다. 이 Form 4는 비파생거래(비-파생상품)만을 공개하며, 이 제출서에는 옵션, 풋, 콜 또는 기타 파생상품 거래가 보고되어 있지 않습니다.

Jay Rosenblum, vice-président exécutif et directeur juridique (CLO) d'Assurant, Inc. (AIZ), a déclaré la vente de 3,900 actions ordinaires d'Assurant le 08/12/2025 à un prix moyen pondéré de $208.5273. Le dépôt indique que les actions ont été vendues lors de plusieurs transactions à des prix allant de $208.1150 à $208.8050, et que la personne ayant effectué la déclaration fournira, sur demande, des détails sur le nombre d'actions vendues à chaque prix. Après la vente déclarée, la participation bénéficiaire de Rosenblum dans les actions ordinaires d'Assurant s'élève à 7,875 actions, que le dépôt précise comprend des unités d'actions restreintes. Le formulaire 4 divulgue uniquement des opérations non dérivées ; aucune option, put, call ou autre opération sur dérivés n'est signalée dans ce document.

Jay Rosenblum, Executive Vice President und Chief Legal Officer (CLO) von Assurant, Inc. (AIZ), meldete am 08/12/2025 den Verkauf von 3,900 Stammaktien von Assurant zu einem gewichteten Durchschnittspreis von $208.5273. Die Meldung führt aus, dass die Aktien in mehreren Transaktionen zu Preisen zwischen $208.1150 und $208.8050 verkauft wurden und dass die meldepflichtige Person auf Anfrage Angaben zur Anzahl der zu jedem Preis verkauften Aktien machen wird. Nach dem gemeldeten Verkauf beträgt Rosenblums wirtschaftliches Eigentum an Assurant-Stammaktien 7,875 Aktien, wobei die Meldung angibt, dass dies eingeschränkte Aktieneinheiten (Restricted Stock Units, RSU) beinhaltet. Das Formular 4 offenbart nur nicht-derivative Transaktionen; Optionen, Puts, Calls oder andere Derivatgeschäfte sind in dieser Meldung nicht angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rosenblum Jay

(Last) (First) (Middle)
C/O ASSURANT, INC.
260 INTERSTATE NORTH CIRCLE SE

(Street)
ATLANTA GA 30339

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ASSURANT, INC. [ AIZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and CLO
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/12/2025 S 3,900 D $208.5273(1) 7,875(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.1150 through $208.8050 inclusive. The reporting person undertakes to provide Assurant, Inc., any security holder of Assurant, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to Form 4.
2. Includes restricted stock units.
Lisa Richter, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jay Rosenblum (AIZ) report on the Form 4?

The filing reports a sale of 3,900 shares of Assurant common stock on 08/12/2025 at a weighted average price of $208.5273.

How many Assurant shares does the reporting person own after the transaction?

Following the reported sale, beneficial ownership is 7,875 shares, and the filing states this total includes restricted stock units.

Were any derivative transactions reported in this Form 4 for AIZ?

No. The filing lists only non-derivative common stock transactions and shows no options, warrants, puts, calls, or other derivative activity.

What price range was disclosed for the sales?

The filing discloses sales executed at prices ranging from $208.1150 to $208.8050, with a weighted average of $208.5273.

Does the Form 4 explain the breakdown of shares sold at each price?

The footnote states the reporting person will provide, upon request, full information about the number of shares sold at each separate price within the disclosed range.
Assurant

NYSE:AIZ

AIZ Rankings

AIZ Latest News

AIZ Latest SEC Filings

AIZ Stock Data

10.38B
50.13M
0.61%
97.95%
1.59%
Insurance - Property & Casualty
Insurance Carriers, Nec
Link
United States
ATLANTA